When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Cytodyn (OTCQB:CYDY) is a triple threat or more with one drug, leronlimab.
HIV
First, is its work on HIV over the past years. Over 800 patients were tested, and since it blocks the CCR5 receptor which is HIV’s known point of entry, it works very well. A BLA (biologics license application) has been sent to the FDA for combination therapy. The next step will be to do whatever testing is required for leronlimab to be approved as a monotherapy.
It seems to have a wonderful safety profile. None of the 800 patients died